Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730)
- 4 June 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 236 (3) , 477-481
- https://doi.org/10.1016/0014-2999(93)90487-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- The complement system in ischemic heart disease.Circulation, 1990
- Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury.Circulation, 1988
- Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissueJournal of Pharmacological Methods, 1988
- Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury.Circulation Research, 1985
- Complement Localization and Mediation of Ischemic Injury in Baboon MyocardiumJournal of Clinical Investigation, 1980
- Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery OcclusionJournal of Clinical Investigation, 1978
- Long-Term Preservation of Ischemic Myocardium after Experimental Coronary Artery OcclusionJournal of Clinical Investigation, 1978